Adenovirus vectors as transcomplementing templates for the production of replication defective retroviral vectors. 1998

W J Ramsey, and N J Caplen, and Q Li, and J N Higginbotham, and M Shah, and R M Blaese
Clinical Gene Therapy Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland 20892, USA. jramsey@nhgri.nih.gov

We have generated an adenovirus containing a retroviral vector sequence encoding the neomycin phosphotransferase (neo) gene (AV-LXSN). AV-LXSN transduction of retroviral packaging cell lines led to production of LXSN retroviral vector with alternative viral envelopes; exposure of target cells to retroviral containing supernatants confirmed envelope specific tropism. Retroviral titers (G418 cfu/ml) were comparable to those produced by standard techniques. Retrovirus could be detected in supernatants within 24 hours of AV-LXSN transduction and persisted as long as 120 hours. Southern blot analysis of DNA purified from populations of G418 cells showed the presence of a single neo containing restriction fragment of the appropriate size that could only be generated by reverse transcription of LXSN to produce LXSN provirus. This adeno-retroviral chimeric vector system could simplify the generation and testing of different retroviral vectors, particularly where assessment of vectors with alternative envelopes carrying novel targeting ligands is required.

UI MeSH Term Description Entries
D003001 Cloning, Molecular The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells. Molecular Cloning
D004340 Drug Contamination The presence of organisms, or any foreign material that makes a drug preparation impure. Drug Adulteration,Drug Contamination, Chemical,Drug Contamination, Microbial,Drug Contamination, Physical,Drug Impurity,Adulteration, Drug,Chemical Drug Contamination,Chemical Drug Contaminations,Contamination, Chemical Drug,Contamination, Drug,Contamination, Microbial Drug,Contamination, Physical Drug,Contaminations, Chemical Drug,Contaminations, Microbial Drug,Contaminations, Physical Drug,Drug Adulterations,Drug Contaminations,Drug Contaminations, Chemical,Drug Contaminations, Microbial,Drug Contaminations, Physical,Drug Impurities,Impurity, Drug,Microbial Drug Contamination,Microbial Drug Contaminations,Physical Drug Contamination,Physical Drug Contaminations
D005822 Genetic Vectors DNA molecules capable of autonomous replication within a host cell and into which other DNA sequences can be inserted and thus amplified. Many are derived from PLASMIDS; BACTERIOPHAGES; or VIRUSES. They are used for transporting foreign genes into recipient cells. Genetic vectors possess a functional replicator site and contain GENETIC MARKERS to facilitate their selective recognition. Cloning Vectors,Shuttle Vectors,Vectors, Genetic,Cloning Vector,Genetic Vector,Shuttle Vector,Vector, Cloning,Vector, Genetic,Vector, Shuttle,Vectors, Cloning,Vectors, Shuttle
D000256 Adenoviridae A family of non-enveloped viruses infecting mammals (MASTADENOVIRUS) and birds (AVIADENOVIRUS) or both (ATADENOVIRUS). Infections may be asymptomatic or result in a variety of diseases. Adenoviruses,Ichtadenovirus,Adenovirus,Ichtadenoviruses
D012190 Retroviridae Family of RNA viruses that infects birds and mammals and encodes the enzyme reverse transcriptase. The family contains seven genera: DELTARETROVIRUS; LENTIVIRUS; RETROVIRUSES TYPE B, MAMMALIAN; ALPHARETROVIRUS; GAMMARETROVIRUS; RETROVIRUSES TYPE D; and SPUMAVIRUS. A key feature of retrovirus biology is the synthesis of a DNA copy of the genome which is integrated into cellular DNA. After integration it is sometimes not expressed but maintained in a latent state (PROVIRUSES). Leukemogenic Viruses,Leukoviruses,Oncornaviruses,Oncovirinae,Oncoviruses,Oncoviruses, Type C,RNA Tumor Viruses,Retroviruses,Type C Oncoviruses,C Oncovirus, Type,C Oncoviruses, Type,Leukemogenic Virus,Leukovirus,Oncornavirus,Oncovirus,Oncovirus, Type C,RNA Tumor Virus,Retrovirus,Tumor Virus, RNA,Tumor Viruses, RNA,Type C Oncovirus,Virus, Leukemogenic,Virus, RNA Tumor,Viruses, Leukemogenic,Viruses, RNA Tumor
D012367 RNA, Viral Ribonucleic acid that makes up the genetic material of viruses. Viral RNA
D014161 Transduction, Genetic The transfer of bacterial DNA by phages from an infected bacterium to another bacterium. This also refers to the transfer of genes into eukaryotic cells by viruses. This naturally occurring process is routinely employed as a GENE TRANSFER TECHNIQUE. Genetic Transduction,Genetic Transductions,Transductions, Genetic
D015316 Genetic Therapy Techniques and strategies which include the use of coding sequences and other conventional or radical means to transform or modify cells for the purpose of treating or reversing disease conditions. Gene Therapy,Somatic Gene Therapy,DNA Therapy,Gene Therapy, Somatic,Genetic Therapy, Gametic,Genetic Therapy, Somatic,Therapy, DNA,Therapy, Gene,Therapy, Somatic Gene,Gametic Genetic Therapies,Gametic Genetic Therapy,Genetic Therapies,Genetic Therapies, Gametic,Genetic Therapies, Somatic,Somatic Genetic Therapies,Somatic Genetic Therapy,Therapies, Gametic Genetic,Therapies, Genetic,Therapies, Somatic Genetic,Therapy, Gametic Genetic,Therapy, Genetic,Therapy, Somatic Genetic
D019065 Virus Assembly The assembly of VIRAL STRUCTURAL PROTEINS and nucleic acid (VIRAL DNA or VIRAL RNA) to form a VIRUS PARTICLE. Viral Assembly,Assembly, Viral,Assembly, Virus
D019868 Kanamycin Kinase A class of enzymes that inactivate aminocyclitol-aminoglycoside antibiotics (AMINOGLYCOSIDES) by regiospecific PHOSPHORYLATION of the 3' and/or 5' hydroxyl. Aminoglycoside Phosphotransferase,Neomycin Phosphotransferase,APH(3')-IIIa,APH(3')-IIb,APHVII,APT-3'-I and II,Amikacin 3'-Phosphotransferase,Aminocyclitol Phosphotransferase,Aminoglycoside 3'-Phosphotransferase Type VIII,Aminoglycoside 3'-Phosphotransferases (I and II),Aminoglycoside Phosphotransferase Type III,Kanamycin-Neomycin Phosphate Transferase,Neomycin Phosphotransferase II,aphVII Gene Product,3'-Phosphotransferase, Amikacin,APT 3' I and II,Amikacin 3' Phosphotransferase,Aminoglycoside 3' Phosphotransferase Type VIII,Kanamycin Neomycin Phosphate Transferase,Kinase, Kanamycin,Phosphate Transferase, Kanamycin-Neomycin,Phosphotransferase II, Neomycin,Phosphotransferase, Aminocyclitol,Phosphotransferase, Aminoglycoside,Phosphotransferase, Neomycin,Transferase, Kanamycin-Neomycin Phosphate

Related Publications

W J Ramsey, and N J Caplen, and Q Li, and J N Higginbotham, and M Shah, and R M Blaese
January 2016, Methods in molecular biology (Clifton, N.J.),
W J Ramsey, and N J Caplen, and Q Li, and J N Higginbotham, and M Shah, and R M Blaese
March 1995, Journal of virology,
W J Ramsey, and N J Caplen, and Q Li, and J N Higginbotham, and M Shah, and R M Blaese
June 2001, Marine biotechnology (New York, N.Y.),
W J Ramsey, and N J Caplen, and Q Li, and J N Higginbotham, and M Shah, and R M Blaese
January 1996, Methods in cell biology,
W J Ramsey, and N J Caplen, and Q Li, and J N Higginbotham, and M Shah, and R M Blaese
January 2003, Methods in molecular medicine,
W J Ramsey, and N J Caplen, and Q Li, and J N Higginbotham, and M Shah, and R M Blaese
January 1999, Virology,
W J Ramsey, and N J Caplen, and Q Li, and J N Higginbotham, and M Shah, and R M Blaese
August 1996, Vaccine,
W J Ramsey, and N J Caplen, and Q Li, and J N Higginbotham, and M Shah, and R M Blaese
October 2002, Current opinion in biotechnology,
W J Ramsey, and N J Caplen, and Q Li, and J N Higginbotham, and M Shah, and R M Blaese
March 1997, Journal of immunological methods,
W J Ramsey, and N J Caplen, and Q Li, and J N Higginbotham, and M Shah, and R M Blaese
May 2001, Current protocols in human genetics,
Copied contents to your clipboard!